海普瑞(09989.HK)孫公司捐贈100萬元支持抗洪搶險救災
格隆匯7月23日丨海普瑞(09989.HK)公佈,近日,河南省出現歷史上極為罕見的持續性極端強降雨,並迅速造成嚴重的內澇和洪災。汛情嚴峻,人民羣眾的生命安全受到威脅,財產遭到破壞,災情牽動全國人民的心。深圳市海普瑞藥業集團股份有限公司(以下簡稱"公司")的全資孫公司深圳市天道醫藥有限公司(以下簡稱"天道醫藥")已向河南省慈善總會捐贈現金人民幣100萬元,由河南省慈善總會統一調配,用於河南省防汛救災、緊急物資採購以及災後重建工作。該事項已經公司於2021年7月23日召開的第五屆董事會第十次會議審議通過。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.